{"id":"W2318409487","doi":"10.1111/igc.0b013e3181e273a8","title":"Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Sorafenib; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Ovarian cancer; Adverse effect; Toxicity; Clinical endpoint; Chemotherapy; Phases of clinical research; Cancer; Clinical trial; Gastroenterology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003087434,0.000138311,0.0003409514,0.0002845166,0.00001633435,0.00002789233,0.0001795268,0.0001089212,0.002412245],"category_scores_gemma":[0.0001632816,0.00009027352,0.00008521457,0.0001915414,0.0000658128,0.0001427335,0.00002935026,0.0005903654,0.000004873664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007436259,"about_ca_system_score_gemma":0.0005265714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005115251,"about_ca_topic_score_gemma":0.007173663,"domain_scores_codex":[0.9985823,0.00003899415,0.0004941574,0.0001865994,0.0005094584,0.0001885078],"domain_scores_gemma":[0.9988894,0.0001475949,0.0002911011,0.00008194747,0.0004787586,0.0001111728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002354354,0.002163306,0.8724349,0.00001212944,0.0002065466,0.001174761,0.0001581506,0.000264385,0.001514608,0.002020981,0.0003220522,0.1173739],"study_design_scores_gemma":[0.01107747,0.0009609927,0.9764825,0.0002622787,0.00005029085,0.00009820343,0.00002766565,0.0001508104,0.001016481,0.0006453022,0.009120322,0.0001076891],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726067,0.000385991,0.00003491757,0.02387193,0.002159709,0.000242699,0.00002571608,0.000006437702,0.0006659472],"genre_scores_gemma":[0.9969693,0.0008799587,0.0007198929,0.0007293678,0.0005146298,0.00009783348,0.00000683804,0.00001112096,0.00007099844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1172662,"threshold_uncertainty_score":0.9984997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01911840457621101,"score_gpt":0.3281520081814268,"score_spread":0.3090336036052158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}